• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.可溶性环氧化物水解酶的药理学抑制或基因缺失可减少双氯芬酸诱导的胃溃疡。
Life Sci. 2017 Jul 1;180:114-122. doi: 10.1016/j.lfs.2017.05.018. Epub 2017 May 15.
2
Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.可溶性环氧化物水解酶抑制剂TPPU对双氯芬酸诱导的肠道溃疡的抗溃疡疗效
J Pharmacol Exp Ther. 2016 Jun;357(3):529-36. doi: 10.1124/jpet.116.232108. Epub 2016 Mar 17.
3
Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.奥美拉唑可增强可溶性环氧化物水解酶抑制剂在PGE₂诱导的疼痛模型中的疗效。
Toxicol Appl Pharmacol. 2015 Dec 15;289(3):419-27. doi: 10.1016/j.taap.2015.10.018. Epub 2015 Nov 10.
4
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.可溶性环氧化物水解酶抑制减轻 MPTP 诱导的黑质纹状体多巴胺能系统神经毒性:涉及α-突触核蛋白聚集和内质网应激。
Mol Neurobiol. 2018 Jan;55(1):138-144. doi: 10.1007/s12035-017-0726-9.
5
1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.1-三氟甲氧基苯基-3-(1-丙酰基哌啶-4-基)脲,一种可溶性环氧化物水解酶和 p38 激酶的选择性和有效的双重抑制剂,干预人神经细胞中的阿尔茨海默病信号通路。
ACS Chem Neurosci. 2019 Sep 18;10(9):4018-4030. doi: 10.1021/acschemneuro.9b00271. Epub 2019 Aug 19.
6
Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.可溶性环氧化物水解酶抑制剂1-三氟甲氧基苯基-3-(1-丙酰基哌啶-4-基)脲减轻博来霉素诱导的小鼠肺纤维化。
Cell Tissue Res. 2016 Feb;363(2):399-409. doi: 10.1007/s00441-015-2262-0. Epub 2015 Aug 28.
7
Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.可溶性环氧化物水解酶抑制剂 TPPU 在小鼠中缺乏奖赏效应:与吗啡的比较。
Neuropsychopharmacol Rep. 2020 Dec;40(4):412-416. doi: 10.1002/npr2.12136. Epub 2020 Sep 7.
8
Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.可溶性环氧化物水解酶的基因缺陷和药理抑制赋予对反复社会挫败应激的恢复力。
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1944-52. doi: 10.1073/pnas.1601532113. Epub 2016 Mar 14.
9
Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.抑制可溶性环氧化物水解酶可减轻四氯化碳诱导的小鼠肝纤维化和内质网应激。
Toxicol Appl Pharmacol. 2015 Jul 15;286(2):102-11. doi: 10.1016/j.taap.2015.03.022. Epub 2015 Mar 28.
10
Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.可溶性环氧化物水解酶抑制剂促进免疫调节抑制骨吸收。
J Periodontal Res. 2018 Oct;53(5):743-749. doi: 10.1111/jre.12559. Epub 2018 May 31.

引用本文的文献

1
Antioxidative Action of Alpha-Linolenic Acid during Its Gastroprotective Effect in an Indomethacin-Induced Gastric Injury Model.α-亚麻酸在吲哚美辛诱导的胃损伤模型中发挥胃保护作用期间的抗氧化作用
Prev Nutr Food Sci. 2025 Apr 30;30(2):132-140. doi: 10.3746/pnf.2025.30.2.132.
2
Soluble epoxide hydrolase inhibitor promotes the healing of oral ulcers.可溶性环氧化物水解酶抑制剂促进口腔溃疡的愈合。
Clinics (Sao Paulo). 2023 May 4;78:100208. doi: 10.1016/j.clinsp.2023.100208. eCollection 2023.
3
Sex-Specific Differences in Resolution of Airway Inflammation in Transgenic Mice Following Repetitive Agricultural Dust Exposure.反复接触农业粉尘后转基因小鼠气道炎症消退的性别差异
Front Pharmacol. 2022 Jan 13;12:785193. doi: 10.3389/fphar.2021.785193. eCollection 2021.
4
Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative.运动至可溶环氧化物水解酶抑制剂 EC5026 的临床应用作为治疗神经性疼痛的镇痛药,也可作为非成瘾性阿片类药物替代物。
J Med Chem. 2021 Feb 25;64(4):1856-1872. doi: 10.1021/acs.jmedchem.0c01886. Epub 2021 Feb 7.
5
Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.解决类二十烷酸/细胞因子风暴可预防致癌物和炎症引发的肝细胞癌进展。
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21576-21587. doi: 10.1073/pnas.2007412117. Epub 2020 Aug 14.
6
COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence.COX-2/sEH 双重抑制剂 PTUPB 通过抑制衰老缓解博来霉素诱导的小鼠肺纤维化。
FEBS J. 2020 Apr;287(8):1666-1680. doi: 10.1111/febs.15105. Epub 2019 Nov 8.
7
Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.环氧-氧化脂质与可溶性环氧化物水解酶代谢途径作为非甾体抗炎药诱导的胃肠病和炎症相关致癌作用的靶点
Front Pharmacol. 2019 Jun 25;10:731. doi: 10.3389/fphar.2019.00731. eCollection 2019.
8
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis.抑制可溶性环氧化物水解酶对犬骨关节炎的药物作用
Front Pharmacol. 2019 May 31;10:533. doi: 10.3389/fphar.2019.00533. eCollection 2019.
9
Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor.糖尿病对链脲佐菌素诱导的糖尿病大鼠雄性性功能的影响:可溶性环氧化物水解酶抑制剂的保护作用。
Biomed Pharmacother. 2019 Jul;115:108897. doi: 10.1016/j.biopha.2019.108897. Epub 2019 May 15.
10
Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes.二十二碳六烯酸增强可溶性环氧化物水解酶抑制剂减轻链脲佐菌素诱导的糖尿病阿尔茨海默病样并发症的效力。
Front Pharmacol. 2019 Apr 24;10:288. doi: 10.3389/fphar.2019.00288. eCollection 2019.

本文引用的文献

1
Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.可溶性环氧化物水解酶抑制剂TPPU对双氯芬酸诱导的肠道溃疡的抗溃疡疗效
J Pharmacol Exp Ther. 2016 Jun;357(3):529-36. doi: 10.1124/jpet.116.232108. Epub 2016 Mar 17.
2
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.新型可溶性环氧水解酶抑制剂GSK2256294的药代动力学、药效学及不良事件概况
Br J Clin Pharmacol. 2016 May;81(5):971-9. doi: 10.1111/bcp.12855. Epub 2016 Jan 17.
3
Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.奥美拉唑可增强可溶性环氧化物水解酶抑制剂在PGE₂诱导的疼痛模型中的疗效。
Toxicol Appl Pharmacol. 2015 Dec 15;289(3):419-27. doi: 10.1016/j.taap.2015.10.018. Epub 2015 Nov 10.
4
Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.抑制可溶性环氧化物水解酶可减轻四氯化碳诱导的小鼠肝纤维化和内质网应激。
Toxicol Appl Pharmacol. 2015 Jul 15;286(2):102-11. doi: 10.1016/j.taap.2015.03.022. Epub 2015 Mar 28.
5
The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.2014年伯纳德·B·布罗迪奖讲座——环氧化物水解酶:从药物代谢到慢性疼痛治疗
Drug Metab Dispos. 2015 May;43(5):788-802. doi: 10.1124/dmd.115.063339. Epub 2015 Mar 11.
6
An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension.二十二碳六烯酸的ω-3环氧化物可降低血管紧张素II依赖性高血压患者的血压。
J Cardiovasc Pharmacol. 2014 Jul;64(1):87-99. doi: 10.1097/FJC.0000000000000094.
7
Protective effect of chelerythrine against ethanol-induced gastric ulcer in mice.白屈菜红碱对乙醇诱导的小鼠胃溃疡的保护作用。
Chem Biol Interact. 2014 Feb 5;208:18-27. doi: 10.1016/j.cbi.2013.11.011. Epub 2013 Dec 1.
8
Current perspectives in NSAID-induced gastropathy.当前对 NSAID 诱导的胃病的看法。
Mediators Inflamm. 2013;2013:258209. doi: 10.1155/2013/258209. Epub 2013 Mar 12.
9
Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.可溶性环氧化物水解酶缺乏或抑制可减轻饮食诱导的肝和脂肪组织内质网应激。
J Biol Chem. 2013 May 17;288(20):14189-14199. doi: 10.1074/jbc.M113.458414. Epub 2013 Apr 10.
10
Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models.取代苯基可改善基于尿素的可溶性环氧化物水解酶抑制剂在小鼠模型中的药代动力学特征和抗炎作用。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):619-27. doi: 10.1016/j.ejps.2012.12.013. Epub 2013 Jan 3.

可溶性环氧化物水解酶的药理学抑制或基因缺失可减少双氯芬酸诱导的胃溃疡。

Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.

作者信息

Goswami Sumanta Kumar, Rand Amelia Ann, Wan Debin, Yang Jun, Inceoglu Bora, Thomas Melany, Morisseau Christophe, Yang Guang-Yu, Hammock Bruce D

机构信息

Department of Entomology and Nematology, and Comprehensive Cancer Center, University of California, Davis, CA 95616, USA.

Department of Pathology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA.

出版信息

Life Sci. 2017 Jul 1;180:114-122. doi: 10.1016/j.lfs.2017.05.018. Epub 2017 May 15.

DOI:10.1016/j.lfs.2017.05.018
PMID:28522175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5659729/
Abstract

AIMS

This research was conducted to evaluate the hypothesis that gastric ulcers caused by the NSAID diclofenac sodium (DCF) can be prevented by the soluble epoxide hydrolase inhibitor TPPU.

MAIN METHODS

Mice were administered a single dose of 10, 30 or 100mg/kg of DCF. Once an ulcerative dose of DCF was chosen, mice were pretreated with TPPU for 7days at 0.1mg/kg to evaluate anti-ulcer effects of the sEH inhibitor on anatomy, histopathology, pH, inflammatory markers and epithelial apoptosis of stomachs.

KEY FINDINGS

Diclofenac caused ulceration of the stomach at a dose of 100mg/kg and a time post dose of 6h. Ulcers generated under these conditions were associated with a significant increase in the levels of TNF-α and IL-6 in serum and increased apoptosis compared to control mice. Pretreatment with TPPU resulted in a decrease of ulceration in mice treated with DCF with a significant decrease in the level of apoptosis, TNF-α and IL-6 in the serum in comparison to diclofenac-treated mice. TPPU did not affect the pH of the stomach, whereas omeprazole elevated the pH of the stomach as expected. A similar anti-ulcer effect was observed in sEH gene knockout mice treated with DCF.

SIGNIFICANCE

The sEH inhibitor TPPU decreases the NSAID-induced stomach ulcers.

摘要

目的

本研究旨在评估可溶性环氧化物水解酶抑制剂TPPU能否预防非甾体抗炎药双氯芬酸钠(DCF)所致胃溃疡这一假说。

主要方法

给小鼠单次给予10、30或100mg/kg的DCF。选定DCF的致溃疡剂量后,用0.1mg/kg的TPPU对小鼠进行7天预处理,以评估sEH抑制剂对胃的解剖结构、组织病理学、pH值、炎症标志物和上皮细胞凋亡的抗溃疡作用。

主要发现

双氯芬酸钠在剂量为100mg/kg且给药后6小时可导致胃溃疡。与对照小鼠相比,在这些条件下产生的溃疡与血清中TNF-α和IL-6水平显著升高以及细胞凋亡增加有关。用TPPU预处理可使DCF处理的小鼠溃疡减少,与双氯芬酸钠处理的小鼠相比,血清中细胞凋亡水平、TNF-α和IL-6显著降低。TPPU不影响胃的pH值,而奥美拉唑如预期那样升高了胃的pH值。在用DCF处理的sEH基因敲除小鼠中也观察到了类似的抗溃疡作用。

意义

sEH抑制剂TPPU可减少非甾体抗炎药引起的胃溃疡。